Latest / Lung Cancer Considered
Virtual Tumor Board: Neoadjuvant for Stage III NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the role of neoadjuvant therapy for stage III NSCLC using a virtual tumor board format. This area has become increasingly complex of late, as we have seen several large studies report encouraging results with peri-operative immunotherapy and targeted therapy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.